- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ 16.867 ↓ -1.25%
[as on 23 January, 2026]
NAV chart
SMA (Simple Moving Average)
Returns
| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|
| HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan | -4.45% | -1.25% | -3.72% | -5.29% | -5.36% | 2.03% | - | - | - | - |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|
| 98.31% |
0.00% (Arbitrage: 0.00%) |
0.00% |
0.00% |
1.69% |
Equity
| Name | Symbol / ISIN | Sector | Weight % |
|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 10.70% |
| Divis Laboratories Ltd. | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 8.87% |
| Lupin Ltd. | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 6.67% |
| Glenmark Pharmaceuticals Ltd. | GLENMARK (INE935A01035) | Pharmaceuticals & Biotechnology | 6.05% |
| Alkem Laboratories Ltd. | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 5.83% |
| Max Healthcare Institute Limited | MAXHEALTH (INE027H01010) | Healthcare Services | 5.49% |
| Ipca Laboratories Ltd. | IPCALAB (INE571A01038) | Pharmaceuticals & Biotechnology | 4.12% |
| Laurus Labs Ltd. | LAURUSLABS (INE947Q01028) | Pharmaceuticals & Biotechnology | 3.80% |
| Aster DM Healthcare Limited | ASTERDM (INE914M01019) | Healthcare Services | 3.71% |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM (INE685A01028) | Pharmaceuticals & Biotechnology | 3.63% |
| Krishna Institute Of Medical Sciences Limited | KIMS (INE967H01025) | Healthcare Services | 3.61% |
| Anthem Biosciences Limited | ANTHEM (INE0CZ201020) | Pharmaceuticals & Biotechnology | 3.50% |
| Cipla Ltd. | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 2.89% |
| Eris Lifesciences Ltd | ERIS (INE406M01024) | Pharmaceuticals & Biotechnology | 2.88% |
| Acutaas Chemicals Limited | ACUTAAS (INE00FF01025) | Pharmaceuticals & Biotechnology | 2.86% |
| Metropolis Healthcare Ltd. | METROPOLIS (INE112L01020) | Healthcare Services | 2.46% |
| Vijaya Diagnostic Centre Limited | VIJAYA (INE043W01024) | Healthcare Services | 2.33% |
| Dr. Lal Path Labs Ltd | LALPATHLAB (INE600L01024) | Healthcare Services | 1.88% |
| Jubilant Pharmova Limited | JUBLPHARMA (INE700A01033) | Pharmaceuticals & Biotechnology | 1.78% |
| Sai Life Sciences Limited | SAILIFE (INE570L01029) | Pharmaceuticals & Biotechnology | 1.72% |
| Wockhardt Ltd. | WOCKPHARMA (INE049B01025) | Pharmaceuticals & Biotechnology | 1.68% |
| Thyrocare Technologies Ltd. | THYROCARE (INE594H01019) | Healthcare Services | 1.58% |
| Piramal Pharma Limited | PPLPHARMA (INE0DK501011) | Pharmaceuticals & Biotechnology | 1.50% |
| Gland Pharma Ltd. | GLAND (INE068V01023) | Pharmaceuticals & Biotechnology | 1.29% |
| Pfizer Ltd. | PFIZER (INE182A01018) | Pharmaceuticals & Biotechnology | 1.29% |
| BAJAJ HEALTHCARE LIMITED | BAJAJHCARE (INE411U01027) | Pharmaceuticals & Biotechnology | 1.27% |
| Ajanta Pharma Limited | AJANTPHARM (INE031B01049) | Pharmaceuticals & Biotechnology | 1.05% |
| Laxmi Dental Limited | LAXMIDENTL (INE0WO601020) | Healthcare Equipment & Supplies | 1.03% |
| Rubicon Research Limited | RUBICON (INE506V01022) | Healthcare Services | 1.00% |
| Fortis Healthcare Limited | FORTIS (INE061F01013) | Healthcare Services | 0.95% |
| Shilpa Medicare Ltd | SHILPAMED (INE790G01031) | Pharmaceuticals & Biotechnology | 0.89% |
Portfolio data is as on date 31 October, 2025
NAV (Net asset value) history
HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan - 30 days NAV history
| Date | NAV |
|---|
| 23 January, 2026 | 16.867 |
| 22 January, 2026 | 17.081 |
| 21 January, 2026 | 16.923 |
| 20 January, 2026 | 16.998 |
| 19 January, 2026 | 17.37 |
| 16 January, 2026 | 17.519 |
| 14 January, 2026 | 17.675 |
| 13 January, 2026 | 17.68 |
| 12 January, 2026 | 17.646 |
| 9 January, 2026 | 17.788 |
| 8 January, 2026 | 17.977 |
| 7 January, 2026 | 18.21 |
| 6 January, 2026 | 18.069 |
| 5 January, 2026 | 17.855 |
| 2 January, 2026 | 17.822 |
| 1 January, 2026 | 17.653 |
| 31 December, 2025 | 17.704 |
| 30 December, 2025 | 17.516 |
| 29 December, 2025 | 17.577 |
| 26 December, 2025 | 17.704 |
| 24 December, 2025 | 17.735 |
| 23 December, 2025 | 17.81 |
| 22 December, 2025 | 17.856 |
| 19 December, 2025 | 17.697 |
| 18 December, 2025 | 17.474 |
| 17 December, 2025 | 17.526 |
| 16 December, 2025 | 17.656 |
| 15 December, 2025 | 17.746 |
| 12 December, 2025 | 17.753 |
| 11 December, 2025 | 17.735 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
The latest NAV of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan is 16.867 as on 23 January, 2026.
What are YTD (year to date) returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
The YTD (year to date) returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan are -4.45% as on 23 January, 2026.
What are 1 year returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
The 1 year returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan are 2.03% as on 23 January, 2026.